Free Trial
NASDAQ:ONVO

Organovo 2/19/2025 Earnings Report

Organovo EPS Results

Actual EPS
-$2.28
Consensus EPS
-$2.52
Beat/Miss
Beat by +$0.24
One Year Ago EPS
N/A

Organovo Revenue Results

Actual Revenue
$0.02 million
Expected Revenue
$0.05 million
Beat/Miss
Missed by -$30.00 thousand
YoY Revenue Growth
N/A

Organovo Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Organovo's next earnings date is estimated for Friday, May 30, 2025, based on past reporting schedules.

Conference Call Resources

Organovo Earnings Headlines

Two new option listings and one option delisting on April 24th
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
VivoSim to Carry Forward Organovo 3D Bioprinting
See More Organovo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organovo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organovo and other key companies, straight to your email.

About Organovo

Organovo (NASDAQ:ONVO), a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

View Organovo Profile

More Earnings Resources from MarketBeat